Figure 3 | Scientific Reports

Figure 3

From: WEE1 kinase polymorphism as a predictive biomarker for efficacy of platinum-gemcitabine doublet chemotherapy in advanced non-small cell lung cancer patients

Figure 3

Validation of WEE1 tag SNPs polymorphisms associated with the efficacy of DNA-damaging agents in 264 patients with advanced NSCLC

A: Kaplan-Meier curve of OS for rs3910384 in patients with NSCLC. B: Kaplan-Meier curve of OS for rs3829254 in patients with NSCLC. C: Kaplan-Meier curve of OS for r4370932 in patients with NSCLC. D: Kaplan-Meier curve of OS for 1049403 in patients with NSCLC.

Back to article page